Imaging breast cancer using hyperpolarized carbon-13 MRI.
Breast Neoplasms
/ diagnostic imaging
Carbon Isotopes
/ chemistry
Female
Humans
Hypoxia-Inducible Factor 1, alpha Subunit
/ genetics
L-Lactate Dehydrogenase
/ genetics
Magnetic Resonance Imaging
/ instrumentation
Monocarboxylic Acid Transporters
/ genetics
Muscle Proteins
/ genetics
Pyruvic Acid
/ chemistry
Symporters
/ genetics
breast cancer
cancer metabolism
magnetic resonance imaging
metabolic imaging
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
28 01 2020
28 01 2020
Historique:
pubmed:
23
1
2020
medline:
2
6
2020
entrez:
23
1
2020
Statut:
ppublish
Résumé
Our purpose is to investigate the feasibility of imaging tumor metabolism in breast cancer patients using
Identifiants
pubmed: 31964840
pii: 1913841117
doi: 10.1073/pnas.1913841117
pmc: PMC6995024
doi:
Substances chimiques
Carbon Isotopes
0
HIF1A protein, human
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Monocarboxylic Acid Transporters
0
Muscle Proteins
0
SLC16A4 protein, human
0
Symporters
0
monocarboxylate transport protein 1
0
Pyruvic Acid
8558G7RUTR
L-Lactate Dehydrogenase
EC 1.1.1.27
Carbon-13
FDJ0A8596D
Types de publication
Evaluation Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2092-2098Subventions
Organisme : Cancer Research UK
ID : C19212/A16628
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 27150
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 21491
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/16
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 28667
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8742/A18097
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C19212/A911376
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/6
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 16465
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C9685/A25177
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 28289
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C197/A16465
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 16942
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 16628
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 17242
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
Copyright © 2020 the Author(s). Published by PNAS.
Déclaration de conflit d'intérêts
Competing interest statement: A research agreement is in place between GE Healthcare and K.M.B. and F.A.G.
Références
N Engl J Med. 2004 Dec 30;351(27):2817-26
pubmed: 15591335
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Magn Reson Imaging Clin N Am. 2013 Aug;21(3):625-39
pubmed: 23928249
Biochemistry. 2014 Dec 2;53(47):7333-57
pubmed: 25369537
Strahlenther Onkol. 2003 Aug;179(8):521-6
pubmed: 14509950
Sci Transl Med. 2013 Aug 14;5(198):198ra108
pubmed: 23946197
Magn Reson Imaging. 2011 Feb;29(2):160-6
pubmed: 21129878
Mol Cancer Res. 2018 Dec;16(12):1889-1901
pubmed: 30037853
J Magn Reson Imaging. 2007 Dec;26(6):1678; author reply 1679
pubmed: 18059007
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Cell Rep. 2016 Feb 23;14(7):1590-1601
pubmed: 26876179
J Magn Reson. 2016 Sep;270:115-123
pubmed: 27434780
Eur Urol. 2017 Dec;72(6):1028-1029
pubmed: 28765011
Breast Cancer (Auckl). 2016 Jul 25;10:103-6
pubmed: 27478380
Nat Med. 2007 Nov;13(11):1382-7
pubmed: 17965722
Eur Radiol. 2016 May;26(5):1474-84
pubmed: 26310583
Radiology. 2017 Nov;285(2):358-375
pubmed: 29045232
Magn Reson Med. 2012 Jul;68(1):8-16
pubmed: 22127962
Ann Surg Oncol. 2017 May;24(5):1251-1257
pubmed: 28008571
Lancet Oncol. 2018 Jan;19(1):27-39
pubmed: 29242041
Mol Biol Rep. 2015 Apr;42(4):841-51
pubmed: 25689954
Proc Natl Acad Sci U S A. 2009 Oct 27;106(43):18131-6
pubmed: 19826085
Radiology. 2016 May;279(2):368-77
pubmed: 26579563
Magn Reson Med. 2018 Sep;80(3):864-873
pubmed: 29322616
Br J Cancer. 2010 Oct 26;103(9):1400-6
pubmed: 20924379
BMC Cancer. 2019 Apr 25;19(1):388
pubmed: 31023265
Curr Opin Genet Dev. 2008 Feb;18(1):54-61
pubmed: 18387799
Cancer Res. 2013 Jan 15;73(2):529-38
pubmed: 23204238
J Biol Chem. 2011 Jul 15;286(28):24572-80
pubmed: 21596745
Breast Cancer Res Treat. 2018 Sep;171(2):295-302
pubmed: 29869774
Br J Surg. 2016 May;103(6):644-655
pubmed: 26990850
BMC Cancer. 2013 Aug 19;13:390
pubmed: 23957561
Neoplasia. 2019 Jan;21(1):1-16
pubmed: 30472500
Tumour Biol. 2013 Jun;34(3):1699-712
pubmed: 23443971
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11270-5
pubmed: 16837573
Magn Reson Med. 1997 Nov;38(5):852-7
pubmed: 9358462
NMR Biomed. 2018 Feb;31(2):
pubmed: 29206323
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Lancet. 2014 Jul 12;384(9938):164-72
pubmed: 24529560
Transl Res. 2017 Nov;189:105-122
pubmed: 28774752
Cancer Res. 2013 Jul 15;73(14):4190-5
pubmed: 23722553
BMJ. 2018 Jan 11;360:j5913
pubmed: 29326104
Cell Metab. 2020 Jan 7;31(1):105-114.e3
pubmed: 31564440
Dis Markers. 2017;2017:7687851
pubmed: 29434411
J Magn Reson Imaging. 2017 Jul;46(1):290-302
pubmed: 27981651
NMR Biomed. 2018 May;31(5):e3901
pubmed: 29457661
Cancer Res. 2008 Oct 15;68(20):8607-15
pubmed: 18922937
J Clin Oncol. 2008 Feb 10;26(5):778-85
pubmed: 18258986
J Magn Reson Imaging. 1999 Sep;10(3):223-32
pubmed: 10508281